Teva Pharmaceutical Industries reported $2.07B in Cost of Sales for its fiscal quarter ending in June of 2025.


Cost Of Sales Change Date
Aspen Pharmacare ZAR 11.51B 1.92B Dec/2024
Cipla INR 24.23B 2.34B Jun/2025
Dr.Reddys Laboratories INR 36.83B 8.33B Jun/2025
Guangzhou Baiy CNY 16.31B 1.56B Jun/2025
Jiangsu Hengrui CNY 1.05B 22.36M Jun/2025
Kalbe Farma IDR 4.94T 205.08B Jun/2025
Richter Gedeon HUF 69.06B 5.08B Sep/2024
Sh Fosun Pharma CNY 5.2B 282.87M Jun/2025
Sun Pharmaceuticals INR 28.15B 1.78B Jun/2025
Teva Pharmaceutical Industries USD 2.07B 97M Jun/2025